Chronic diseases represent an increasingly significant challenge for the healthcare system, especially when they affect the elderly who require long-term care. In Umbria the problem is particularly felt for the percentage of the over-65 population who are often followed and cared for at home. To manage these particular conditions, medical expertise is not enough but innovative devices are needed that can facilitate the work of caregivers. The availability of home assistants plays a crucial role in Umbria and some data certify that approximately 33% of Italian families need continuous assistance but of these only 5% manage to obtain external help.
This means that the vast majority of families must ensure assistance and care independently. According to the latest available official data published by AUR (Umbria Research Agency), the average age has risen to 47.8 years and the over 65 population is equal to 26.6% of the total, with growth between 2012 and 2022 of over 20 thousand people, in short, a “hidden” city larger than Orvieto was born in Umbria, populated only by elderly people.
The choice of specific products is therefore of great importance as he underlines Fulvia Lazzarotto, CEO of Welcare Industries, which are effective and easy to use for the many non-professional caregivers. Welcare, one of the leading companies in the sector based in Orvieto, can offer the right solutions to improve the quality of life of both patients and their caregivers. Among the various devices developed by Welcare, the UCS® Debridement system stands out for the management of chronic skin lesions. These injuries require thorough cleaning and treatments that promote healing. Cleansing and debridement are essential steps to create an environment conducive to healing, removing contaminants and reducing biofilm formation.
During the latest edition of the EWMA (European Wound Management Association) in London, a study was presented demonstrating the effectiveness of the UCS system® Debridement in the treatment of chronic skin lesions. This sterile medical device is designed to improve and facilitate cleaning and mechanical debridement; it is effective in removing biofilm, reducing pain, operating times and bleeding, and improving the condition of the skin surrounding the lesion. The study involved 40 patients with chronic lesions of various origins, with an average age of 62 years (range 27-88), equally divided between men and women.
Patients were observed for 42 days, with regular assessments (T0, T14, T28, T42). The results are remarkable with a reduction of the lesion area by an average of 62% and 92.5% of patients with an average above 50%. The study also highlighted a strong reduction in painup to 92% from the start of treatment and a elimination of infections in 32 cases out of 40. Lastly, a improvement of the perilesional skin with complete resolution of xerosis/scaling and maceration, e significant reduction in inflammation and bleeding.
The importance of a medical device such as this is therefore evident UCS® Debridement in supporting patients and caregivers. The management of these pathologies is a complex but not impossible challenge, especially thanks to companies like Welcare always looking for innovative solutions to support both professional and non-professional caregivers. With the UCS® Debridement line by Welcare Industries on the one hand the quality of life of patients is improved and on the other the physical and emotional burden of caregivers. Continued research and development in this field is essential to address the growing needs of the elderly population and ensure high-quality home care.
For more information on the product or to purchase click here: https://www.welcareindustries.com/it/chronic-lesions/8-ucsol-debridement.html
